Y-Q Wei

发表

MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.

Binghui Kong, S. Li, X. Jiao, 2019, European review for medical and pharmacological sciences.

SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants

L. Zhong, R. Zheng, Z. Cao, 2012, Leukemia.